# US 2013/0156819 A1 · Isolation of mesenchymal stem cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0156819 A1
- Document ID: US20130156819A1
- Status: Published application
- Kind: A1
- Application number: 13/706,308
- Filed: 2012-12-05
- Published: 2013-06-20
- Earliest claimed: 2010-06-07
- Assignees: Baden-Württemberg Stiftung gGmbH; Eberhard-Karls-Universit°t Tübingen Universit°tsklinikum
- Inventors: Wilhelm Aicher; Brigitte Angres
- Web page: https://patentgrep.com/patent/US20130156819A1

## CPC

- C07K 7/06: having 5 to 11 amino acids
- A61K 35/28: Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
- A61L 31/08: Materials for coatings
- A61L 31/16: Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)}
- C07K 5/0808: {the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu}
- C07K 5/1008: {the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala}
- C07K 5/101: {the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu}
- C07K 5/1016: {and aromatic or cycloaliphatic}
- C07K 7/08: having 12 to 20 amino acids (gastrins C07K14/595; somatostatins C07K14/655; melanotropins C07K14/68)
- C07K 14/47: from mammals
- C07K 14/78: Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
- C12N 5/0068: {General culture methods using substrates (for specific animal cell type C12N5/06)}
- C12N 5/0663: {Bone marrow mesenchymal stem cells (BM-MSC)}
- C12N 5/0668: {Mesenchymal stem cells from other natural sources}
- A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00)
- A61K 2035/124: {the cells being hematopoietic, bone marrow derived or blood cells}
- C12N 2533/00: Supports or coatings for cell culture, characterised by material
- C12N 2533/52: Fibronectin; Laminin
- C12N 2533/54: Collagen; Gelatin
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention relates to peptides or fragments thereof, which peptides bind to mesenchymal stem cells. The present invention also relates to a method for identifying, isolating, specifically selecting and/or enriching mesenchymal stem cells, wherein the peptides, or fragments thereof, are employed for specifically binding to the mesenchymal stem cells. Also, the present invention relates to the use of the peptides of the invention, or fragments thereof, and of the mesenchymal stem cells isolated with the peptides of the invention, or fragments thereof, for treating, injuries and/or degenerated bone, cartilage or tissues.

## Claims

### Claim 1

A method for selecting and/or enriching mesenchymal stem cells (MSCs) from a sample, comprising the steps of
contacting a sample containing mesenchymal stem cells and other cell types with a peptide, or a fragment thereof, wherein the peptide or fragment thereof specifically binds to mesenchymal stem cells, and wherein the peptide is selected from the group consisting of laminin-1, collagen-1, collagen-3, collagen-4, tenascin, thrombospondin-1, osteopontin, fibronectin, vitronectin, and mixtures thereof, thereby allowing binding of the peptide or fragment thereof to mesenchymal stem cells,
selecting and/or enriching the mesenchymal stem cells bound to the peptide or fragment thereof from the other cell types not bound to the peptide or fragment thereof.

### Claim 2 (depends on 1)

The method as claimed in claim 1, wherein the peptide fragment is:
a) a peptide consisting of the amino acid sequence set forth as one of SEQ ID NOs: 8 to 32;
b) fragments of the sequences according to a), which have a substantially identical biological activity of the peptide according to a) in an assay relating to the binding of mesenchymal stem cells; or
c) a peptide fragment with a sequence that is at least 80% identical one of the sequences stated in a) and b).

### Claim 3 (depends on 1)

The method as claimed in claim 1, wherein the sample is from a primary culture or a previously cultured cell population.

### Claim 4 (depends on 1)

The method as claimed in claim 1, wherein the peptide or fragment thereof is labelled.

### Claim 5 (depends on 1)

The method as claimed in claim 1, wherein the selecting and/or enriching step comprises identifying and/or isolating the MSCs bound to the peptide or fragment thereof.

### Claim 6 (depends on 1)

The method as claimed in claim 1, wherein the step of selecting and/or enriching is in vivo, in situ or in vitro.

### Claim 7 (depends on 1)

The method as claimed in claim 1, further comprising the step of inducing proliferation and/or differentiation of the MSCs bound to the peptide or fragment thereof, wherein the proliferation and/or differentiation is induced by the peptide and/or fragment thereof.

### Claim 8

A method for treating wounds, injuries and/or degenerated bone, cartilage or tissues comprising administering to a patient in need thereof a peptide consisting of one of the amino acid sequences set forth as SEQ ID NOs: 8 to 32, or mixtures thereof, thereby treating the wounds, injuries and/or degenerated bone, cartilage or tissues.

### Claim 9 (depends on 8)

The method as claimed in claim 8, comprising administering to the subject an implant or stent coated with the peptide.

### Claim 10

A method for the production of an implant, the method comprising the step of
coating the implant with a peptide consisting of the amino acid sequence set forth as one of SEQ ID NOs: 8 to 32, or mixtures thereof, thereby producing the implant.

### Claim 11 (depends on 1)

Method for treating wounds, injuries and/or degenerated bone, cartilage or tissues comprising administering to a patient in need thereof a mesenchymal stem cell that has been selected or enriched according to the method as claimed in claim 1.

### Claim 12

Synthetic, isolated or recombinant peptide, consisting of an amino acid sequence selected from the group consisting of:
a) the amino acid sequence set forth as one of SEQ ID NOs: 8 to 3;
b) fragments of the sequences according to a), which possess the biological activity of the peptide according to a) in an assay relating to the binding of mesenchymal stem cells; and
c) fragments with a sequence that is identical to at least 80%- to one of the sequences stated in a) and b).

### Claim 13 (depends on 12)

A pharmaceutical composition comprising at least a) one peptide as claimed in claim 12 and b) a pharmaceutically acceptable carrier.
